Orexo AB (ORXOF)
2.10
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Orexo EPS Diluted (Quarterly) : -0.417 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Swedencare AB | 0.0121 |
| Camurus AB | 0.263 |
| Moberg Pharma AB | -0.003 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.51M |
| Revenue (Quarterly) | 0.547M |
| Total Expenses (Quarterly) | 12.06M |
| Enterprise Value | 33.96M |
| Gross Profit Margin (Quarterly) | -86.00% |
| Profit Margin (Quarterly) | -2.10K% |
| Earnings Yield | -36.27% |
| Normalized Earnings Yield | -36.27 |